Germantown startup NextCure Inc. has raised $67 million in Series A financing for a plan to commercialize the work of a scientist credited with discovering a key pathway for how cancer drugs harness the immune system, it was announced Wednesday.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2016/01/new-germantown-immunotherapy-startup-launches-with.html?ana=e_du_pap&s=article_du&ed=2016-01-06&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1452111670{/iframe}